Abstract
The effect of estrogen administration on eosinophil infiltration into the uterus was examined. To investigate the role of mast cells in eosinophil infiltration, genetically mast cell-deficient (W/Wv) mice were used. The ovariectomized W/Wv mice were injected subcutaneously with 7 doses (0.001-0.25μg/g BW) of estradiol-17β (E2) once a day for 2 days. The treatment resulted in significant increases in the uter-ine weight and the number of uterine eosinophils compared to the vehicle-injected control W/Wv mice 24 hrs after the second injection. Although the increases were dependent on the dose of E2 administered, the magnitude of the responses was maximal in the uterus treated with the doses over 0.05μg/g BW. Fur-thermore the uterine weight in the treated mice was not increased between 24 and 48 hrs after the second injection of E2 (0.15 μg/g BW). On the other hand, the number of eosinophils was increased until 48 hrs after the injection. The E2 treatment at a dose of 0.15 μg/g BW resulted in a significant increase in histamine content of the uterus than that of the vehicle-injected control. However, there was no difference in the con-centration of the uterine histamine between the treated and control groups. These data suggest that the E2 induced uterine eosinophilia is not mediated by mast cells in the W/Wv mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.